drugset / Trial / NCT05918406
Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to determine the safety of the nasal guide when utilized to aid in the administration of Tyrvaya (varenicline solution 0.03mg) Nasal Spray
Timeline
- Start
- 2023-06-14
- Primary completion
- 2023-08-18
- Completion
- 2023-08-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Nasal Guide | Unknown | 0.03 mg | — |